← Back to Search

Mindfulness for Breast Cancer

N/A
Waitlist Available
Led By Lisa Golman-Rosas, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Comorbid bipolar affective disorder or psychotic disorder
Other diagnosis besides invasive breast cancer (ie Ductal carcinoma in situ (DCIS), fibroadenoma, abnormal mammogram but not yet with final diagnosis, non-breast cancer patients)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year

Summary

This trial is testing a mindfulness program to see if it can help Latina breast cancer patients with anxiety and depression.

Who is the study for?
This trial is for Spanish-speaking Latinas who have had breast cancer treatment or endocrine therapy in the last year. They must identify as having anxiety, depression, or sleep disturbances and be able to sign consent. It's not for those with other diagnoses besides invasive breast cancer, non-Spanish speakers, certain mental health conditions, inability to attend sessions, or current participation in similar programs.
What is being tested?
The study tests a mindfulness program translated into Spanish and delivered by a trained community health worker. Its cultural acceptability and feasibility are evaluated alongside its effectiveness at reducing anxiety and depression among Latina breast cancer patients.
What are the potential side effects?
Since this trial involves a mindfulness program rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal experiences during group sessions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with bipolar disorder or a psychotic disorder.
Select...
I have a breast condition but it's not invasive breast cancer.
Select...
I do not speak Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability change across session
Difference in Feasibility
Secondary study objectives
Differences in Center for Epidemiological Studies-Depression (CES-D) between time points.
Differences in Generalized Anxiety Disorder-7 (GAD7) between time points.
Differences in PROMIS-SD between time points

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Mindfulness group visitActive Control1 Intervention
Participants will attend 6 weekly educational and mindfulness sessions
Group II: Wait list controlPlacebo Group1 Intervention
Participants will be placed on a wait list

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,475 Previous Clinical Trials
17,501,452 Total Patients Enrolled
Lisa Golman-Rosas, PhDPrincipal InvestigatorStanford University
Maria G Juarez-Reyes, MD, PhDStudy DirectorStanford University

Media Library

Mindfulness Clinical Trial Eligibility Overview. Trial Name: NCT04834154 — N/A
Depression and Anxiety Research Study Groups: Mindfulness group visit, Wait list control
Depression and Anxiety Clinical Trial 2023: Mindfulness Highlights & Side Effects. Trial Name: NCT04834154 — N/A
Mindfulness 2023 Treatment Timeline for Medical Study. Trial Name: NCT04834154 — N/A
~7 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top